Acquisition of italian service company

May 27, 2009 Group News

Cryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, announces that it has agreed to acquire Salus Futura Ltd, United Kingdom, which holds all shares of Salus Futura Srl, Italy (“Salus Futura”), for an initial consideration of €0.4 million payable in cash and a deferred performance related payment, payable annually on the achievement of certain goals until 31 May 2012. The total consideration under the agreement has been capped to avoid the need for shareholder approval. Cryo-Save expects the acquisition to be earnings enhancing on completion.

read more